journal article·2025-02-21

Controlled Delivery of Cytarabine in Sodium Carboxymethyl Cellulose/Copper-Doped Prussian Blue Hydrogels for Chemotherapy and Chemodynamic Therapy

Jun Gao, Rongzhi Wang, Zhengyin Liang, Zherui Zhao, Yong Kong, Min Zhou

ACS Applied Nano Materials· Volume 8· Issue 7
Publisher page

Abstract

To improve the therapy of chemotherapy for cancer treatment, hydrogels of sodium carboxymethyl cellulose (CMC)/copper-doped Prussian blue (CDPB) are synthesized for the controlled delivery of cytarabine (Cyt). CMC is connected to 3-aminophenylboronic acid (PBA) and dopamine (DA), respectively, by amidation reactions, and the obtained CMC-PBA and CMC-DA are cross-linked through boronate affinity for the encapsulation of CDPB and Cyt. The resultant CMC/CDPB/Cyt hydrogels can, respectively, respond to pH and H 2 O 2, and thus, pH- and H 2 O 2 -responsive delivery of Cyt from the hydrogels is successfully achieved. More importantly, the overexpressed H 2 O 2 in cancer cells can be converted to hydroxyl radicals ( • OH) by the CDPB in the hydrogels through Fenton-like reactions, and the generated • OH can participate in the chemodynamic therapy (CDT) of cancers. Due to the combination treatment of chemotherapy and CDT, enhanced anticancer effects are obtained by using human acute promyelocytic leukemia (HL-60) cell lines as the model target.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics

Changzhou Municipal Hospital of Traditional Chinese Medicine

Queen Mary School

Nanchang University

Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology, School of Petrochemical Engineering

Changzhou University

Department of Hematology and Oncology

Changzhou No. 3 People’s Hospital

Funding

Nanjing University of Chinese Medicine · Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China

References (36)

Show source-provided references
1. 10.1016/j.semcancer.2019.11.00210.1016/j.semcancer.2019.11.002 ↗
2. 10.1016/j.drup.2022.10091610.1016/j.drup.2022.100916 ↗
3. 10.3390/pharmaceutics1412256110.3390/pharmaceutics14122561 ↗
4. 10.1016/j.eurpolymj.2023.11243710.1016/j.eurpolymj.2023.112437 ↗
5. 10.1016/j.ijbiomac.2023.12361610.1016/j.ijbiomac.2023.123616 ↗
6. 10.1002/bkcs.1249910.1002/bkcs.12499 ↗
7. Wang S. · Chin. Clin. Oncol. · 2008 · 13 · 197
8. 10.1016/S0304-3835(97)00218-810.1016/S0304-3835(97)00218-8 ↗
9. 10.1021/mp070045810.1021/mp0700458 ↗
10. 10.1038/s41427-021-00354-410.1038/s41427-021-00354-4 ↗
11. 10.1016/j.ijbiomac.2022.10.21510.1016/j.ijbiomac.2022.10.215 ↗
12. 10.1002/adma.20190602410.1002/adma.201906024 ↗
13. 10.1002/anie.20200938010.1002/anie.202009380 ↗
14. 10.1002/smll.20210386810.1002/smll.202103868 ↗
15. 10.1080/00222348.2011.56319610.1080/00222348.2011.563196 ↗
16. 10.1016/j.ijbiomac.2018.11.11810.1016/j.ijbiomac.2018.11.118 ↗
17. 10.1016/j.eurpolymj.2021.11050010.1016/j.eurpolymj.2021.110500 ↗
18. 10.1016/j.carbpol.2021.11832510.1016/j.carbpol.2021.118325 ↗
19. 10.1016/j.ijbiomac.2022.01.03310.1016/j.ijbiomac.2022.01.033 ↗
20. 10.1016/j.apsb.2021.08.02110.1016/j.apsb.2021.08.021 ↗
21. 10.1016/j.colsurfb.2020.11153810.1016/j.colsurfb.2020.111538 ↗
22. 10.1016/j.jcis.2021.09.18610.1016/j.jcis.2021.09.186 ↗
23. 10.1016/j.mssp.2014.10.01410.1016/j.mssp.2014.10.014 ↗
24. 10.1016/j.jcis.2021.11.18310.1016/j.jcis.2021.11.183 ↗
25. 10.1016/j.msec.2015.07.06810.1016/j.msec.2015.07.068 ↗
26. 10.1021/acsanm.2c0144810.1021/acsanm.2c01448 ↗
27. 10.12162/jbb.v4i3.00610.12162/jbb.v4i3.006 ↗
28. 10.1016/j.biomaterials.2022.12184910.1016/j.biomaterials.2022.121849 ↗
29. 10.1248/jhs.55.31910.1248/jhs.55.319 ↗
30. 10.1007/s11356-022-24618-w10.1007/s11356-022-24618-w ↗
31. 10.1016/j.polymdegradstab.2013.12.01110.1016/j.polymdegradstab.2013.12.011 ↗
32. 10.1080/25740881.2021.193401710.1080/25740881.2021.1934017 ↗
33. 10.1021/acsami.6b0295510.1021/acsami.6b02955 ↗
34. 10.1016/j.ijbiomac.2022.10.04110.1016/j.ijbiomac.2022.10.041 ↗
35. 10.1080/00914037.2019.167017910.1080/00914037.2019.1670179 ↗
36. 10.1039/D0DT02220A10.1039/D0DT02220A ↗